A cyano-bridged CuII–NiII dimeric complex [Cu(Me6Cy)][Ni(CN)4] has been synthesized and characterized by its single crystal X-ray structure determination. The square planar [Cu(Me6Cy)]2+ cation is converted to a distorted trigonal bipyramidal (TBP) geometry through ligation to one of the cyano groups of [Ni(CN)4]2− in the equatorial plane, keeping the other three as terminal. Inspection of the X-ray data reveals that the Cu–N(6)–C(6) angle of the bridging cyano group is perfectly linear (180°). The room temperature (RT) EPR spectrum of polycrystalline [Cu(Me6Cy)][Ni(CN)4] is typical for mononuclear copper(II) complexes of axial symmetry, where the flattened out symmetry axis is characterized by g⊥ = 2.143 ± 0.005 and g‖ = 2.002 ± 0.005. No half field (ΔM = 2) signals were observed. RT EPR spectrum of polycrystalline [CuII(Me6Cy)](ClO4)2 yields an EPR signal with g‖ = 2.394 ± 0.005 and g⊥ = 2.045 ± 0.005, indicating that this parent compound has a different geometry than [Cu(Me6Cy)][Ni(CN)4]. Variable temperature magnetic moment studies on [Cu(Me6Cy)][Ni(CN)4] indicate a very weak long-range ferromagnetic exchange through hydrogen bonding between copper(II) ions (S = ½). The present investigation provides a unique example where the original square planar [Cu(Me6Cy)]2+ moiety rearranges itself to a trigonal bipyramidal geometry under the influence of [Ni(CN)4]2−. This is probably only the second, rare example, and perhaps the first, for a macrocyclic precursor using only one cyano group of [Ni(CN)4]2− for bridging, leading to a discrete dinuclear complex.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: